Negative and Deficit Symptoms in Schizophrenia Do Respond to Neuroleptics
نویسندگان
چکیده
منابع مشابه
The Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملNegative Symptoms and Negative Schizophrenia
This study determines the frequency distribution of prominent negative symptoms in a group of chronic, hospitalised schizophrenics. Thirty chronic Schizophrenic (D.S.M. III) patients were rated on the scale for Assessment of Negative Symptoms (SANS) and the prominent negative symptoms were correlated with age, sex and certain illness variables. Majority (80%) of patients had some or the other n...
متن کاملThe Effects of Bupropion on Negative Symptoms in Schizophrenia
Abstract:Purpose:This study was designed determine the efficacy of bupropion versus placebo in subjects with negative symptoms of schizophrenia.Methods:A convenience sample of 40 patients of both genders aged 18-60 years who were living in psychiatric care centers were randomly treated with bupropion (started with 75 mg twice a day; increased to 100 mg thrice daily) or placebo. The diagnosis of...
متن کاملElevated noise power in gamma band related to negative symptoms and memory deficit in schizophrenia.
BACKGROUND There is an increasing consideration for a disorganized cerebral activity in schizophrenia, perhaps relating to a synaptic inhibitory deficit in the illness. Noise power (scalp-recorded electroencephalographic activity unlocked to stimuli) may offer a non-invasive window to assess this possibility. METHODS 29 minimally-treated patients with schizophrenia (of which 17 were first epi...
متن کاملNegative Symptoms in Schizophrenia Respond to Milnacipran Augmentation Therapy: A Case Report
We report a 37-year-old male patient with schizophrenia and negative symptoms including blunted affect, avolition, alogia and asociality. Unexpectedly, the addition of milnacipran, a serotonin and noradrenaline reuptake inhibitor and approved as an antidepressant, to his existing psychotropic regimen including aripiprazole selectively improved his negative symptoms. The present findings suggest...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Schizophrenia Bulletin
سال: 1985
ISSN: 0586-7614,1745-1701
DOI: 10.1093/schbul/11.3.453